"Baltimore wins another $45 million from a drug company in opioid litigation," 12 August 2024

Baltimore has reached a second $45 million settlement in its lawsuit against multiple pharmaceutical companies and drug stores for their part in the city’s opioid crisis.

The agreement... with CVS comes two months after the city reached a similar agreement with Allergan Finance...

CVS denies any wrongdoing in the settlement, which has resolved all city claims against the drug chain, said Michael Deangelis, the executive director of corporate communications for CVS.

“CVS will no longer be a defendant in the city’s opioid distribution lawsuit that is scheduled for trial in September 2024. Putting these claims behind us is in the best interest of all parties and the agreement does not constitute an admission of wrongdoing,” Deangelis said in a statement to Maryland Matters...